HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher J Schmidt Selected Research

2- ((4- (1- methyl- 4- pyridin- 4- yl- 1H- pyrazol- 3- yl)phenoxy)methyl)quinoline

11/2019Phosphodiesterase 10A Inhibitor Monotherapy Is Not an Effective Treatment of Acute Schizophrenia.
7/2019A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher J Schmidt Research Topics

Disease

16Schizophrenia (Dementia Praecox)
01/2020 - 01/2007
7Cognitive Dysfunction
01/2019 - 01/2010
4Psychotic Disorders (Schizoaffective Disorder)
01/2020 - 08/2006
3Huntington Disease (Huntington's Disease)
12/2016 - 01/2011
2Neurodegenerative Diseases (Neurodegenerative Disease)
05/2012 - 08/2006
1Breast Neoplasms (Breast Cancer)
12/2022
1Dystonia (Limb Dystonia)
11/2019
1Inflammation (Inflammations)
08/2017
1Vomiting
08/2017
1Nausea
08/2017
1Uveitis
08/2017
1Mental Disorders (Mental Disorder)
01/2017
1Substance-Related Disorders (Drug Abuse)
01/2017
1Parkinson Disease (Parkinson's Disease)
12/2014
1Basal Ganglia Diseases (Basal Ganglia Disease)
12/2014
1Tremor (Tremors)
10/2013
1Alzheimer Disease (Alzheimer's Disease)
11/2012
1Catalepsy
08/2006

Drug/Important Bio-Agent (IBA)

12Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
11/2019 - 08/2006
6Antipsychotic Agents (Antipsychotics)IBA
01/2020 - 08/2006
3KetamineFDA LinkGeneric
09/2010 - 03/2010
22- ((4- (1- methyl- 4- pyridin- 4- yl- 1H- pyrazol- 3- yl)phenoxy)methyl)quinolineIBA
11/2019 - 07/2019
2EnzymesIBA
01/2019 - 10/2011
2Neurotransmitter Agents (Neurotransmitter)IBA
05/2012 - 01/2011
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2011 - 06/2010
2Glycine Plasma Membrane Transport ProteinsIBA
03/2010 - 02/2010
1Proteins (Proteins, Gene)FDA Link
12/2022
1Glycoproteins (Glycoprotein)IBA
12/2022
1Risperidone (Risperdal Consta)FDA LinkGeneric
11/2019
1IsoenzymesIBA
08/2017
1LipopolysaccharidesIBA
08/2017
1SteroidsIBA
08/2017
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
08/2017
1EndotoxinsIBA
08/2017
1Dopamine Receptors (Dopamine Receptor)IBA
01/2017
1SulfonamidesIBA
05/2015
1PropaneIBA
05/2015
1tetrahydrofuranIBA
05/2015
1Pharmaceutical PreparationsIBA
12/2014
1AcidsIBA
10/2013
1PF-4778574IBA
10/2013
1PyransIBA
11/2012
1Serine (L-Serine)FDA Link
10/2011
1D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA
10/2011
1N-Methylaspartate (NMDA)IBA
10/2011
1Methamphetamine (Desoxyn)FDA LinkGeneric
03/2011
1Mescaline (Peyote)IBA
03/2011
1metabotropic glutamate receptor 2IBA
03/2011
1Neuroprotective AgentsIBA
01/2011
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
09/2010
1AMPA Receptors (AMPA Receptor)IBA
09/2010
11-methyl-1H-imidazole-4-carboxylic acid (3- chloro- 4- fluoro- benzyl)- (3- methyl- 3- aza- bicyclo(3.1.0) hex-6-ylmethyl)amideIBA
03/2010
1Phosphodiesterase InhibitorsIBA
01/2010
1quinolineIBA
08/2009
1Haloperidol (Haldol)FDA LinkGeneric
08/2006
1PapaverineIBA
08/2006

Therapy/Procedure

3Therapeutics
01/2020 - 11/2012